Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00602836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.
ClinicalTrials.gov study NCT00738374. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02530515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00541034. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
ClinicalTrials.gov study NCT01056510. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01510756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00949988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01082939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
ClinicalTrials.gov study NCT01030536. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT01515176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02612311. IPD Sharing: NO. Countries: 7. Publications: 0.
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
ClinicalTrials.gov study NCT00632359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
ClinicalTrials.gov study NCT01271010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01027000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)
ClinicalTrials.gov study NCT01650727. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03737981. IPD Sharing: YES. Countries: 1. Publications: 0.
Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00398112. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission
ClinicalTrials.gov study NCT00476047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01003769. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01532700. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.